Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

2.7K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.7K
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

1.9K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.9K
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

1.7K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.7K
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

3.7K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
3.7K
Direct-Acting Cholinergic Agonists: Therapeutic Uses01:11

Direct-Acting Cholinergic Agonists: Therapeutic Uses

1.5K
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
1.5K
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

938
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
938

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early Optic Nerve Head Swelling Rate Is Associated with Worsening of Visual Outcomes in Nonarteritic Anterior Ischemic Optic Neuropathy.

Ophthalmology·2026
Same author

Time is vision: a systematic review of urgent venous sinus stenting for fulminant idiopathic intracranial hypertension.

Frontiers in neurology·2026
Same author

Economic Evaluation of Thymectomy for the Treatment of Nonthymomatous Myasthenia Gravis.

JAMA network open·2026
Same author

From Observation to Prediction: Machine Learning Analysis of Progression of Visual loss in Nonarteritic Anterior Ischemic Optic Neuropathy.

American journal of ophthalmology·2026
Same author

Natural Language Processing to Automate Cerebrovascular Event Identification in Stroke Alerts.

Stroke (Hoboken, N.J.)·2026
Same author

Progression of Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) Occurs Early and Is Unassociated With Modifiable Risk Factors.

American journal of ophthalmology·2026
Same journal

Explainable machine learning-based preliminary screening for viral encephalitis by blood routine analysis.

Frontiers in neurology·2026
Same journal

Global landscape of registered clinical trials of stem cell therapy for spinal cord injury: a cross-sectional analysis.

Frontiers in neurology·2026
Same journal

Experimental verification and PK/PD modeling of selective drug absorption via acupoint administration in rabbit model of rheumatoid arthritis.

Frontiers in neurology·2026
Same journal

Plasma metabolomic signatures of the no-reflow phenomenon in stroke patients following thrombectomy.

Frontiers in neurology·2026
Same journal

Parametric color-coding-derived microvascular transit time may predict infarction and reveals microcirculatory benefits of Tenecteplase in acute ischemic stroke.

Frontiers in neurology·2026
Same journal

The application of fNIRS-sEMG in the study of muscle-brain coupling.

Frontiers in neurology·2026
See all related articles

Related Experiment Video

Updated: Jan 11, 2026

Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

12.8K

Ocular myasthenia gravis management.

Mark J Kupersmith1, Gil I Wolfe2, Henry Kaminski3

  • 1Department of Ophthalmology, Icahn School of Medicine at Mount Sinai, New York Eye and Ear Infirmary and Union Square Eye Care, New York, NY, United States.

Frontiers in Neurology
|November 19, 2025
PubMed
Summary
This summary is machine-generated.

Ocular myasthenia gravis (OMG) lacks clear diagnostic and management guidelines, causing misdiagnoses. This review offers clinical guidance for diagnosing and treating OMG based on literature and expert experience.

Keywords:
OMGOMG mimicsmyasthenia gravis diagnosismyasthenia gravis treatmentocular myasthenia gravis

Related Experiment Videos

Last Updated: Jan 11, 2026

Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

12.8K

Area of Science:

  • Neurology
  • Ophthalmology

Background:

  • Ocular myasthenia gravis (OMG) presents diagnostic and therapeutic challenges due to a lack of standardized criteria.
  • This ambiguity frequently results in patient misdiagnosis and suboptimal treatment strategies.

Purpose of the Study:

  • To provide essential guidance for clinicians managing patients with suspected ocular myasthenia gravis.
  • To establish evidence-based recommendations for the diagnosis and management of OMG.

Main Methods:

  • A comprehensive review of existing literature on myasthenia gravis and ocular myasthenia gravis.
  • Integration of the authors' extensive clinical experience in diagnosing and treating OMG.

Main Results:

  • The review synthesizes current knowledge to address the diagnostic and management gaps in OMG.
  • Authors present practical recommendations derived from both published data and clinical practice.

Conclusions:

  • Standardized criteria are crucial for accurate OMG diagnosis and effective treatment.
  • This minireview aims to improve clinical decision-making and patient outcomes in ocular myasthenia gravis.